Literature DB >> 31821096

Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop.

Rupesh Agrawal1,2,3, Aniruddha Agarwal4, Douglas A Jabs5,6, Aera Kee1, Ilaria Testi2, Sarakshi Mahajan7, Peter J McCluskey8, Amod Gupta4, Alan Palestine9, Alastair Denniston10, Alay Banker11, Alessandro Invernizzi12, Alex Fonollosa13, Aman Sharma14, Amitabh Kumar15, Andre Curi16, Annabelle Okada17, Ariel Schlaen18, Arnd Heiligenhaus19, Atul Kumar20, Avinash Gurbaxani2, Bahram Bodaghi21, Bulbul Islam Shah22, Careen Lowder23, Christoph Tappeiner24, Cristina Muccioli25, Daniel Vitor Vasconcelos-Santos26, Debra Goldstein27, Digambar Behra28, Dipankar Das29, Dorine Makhoul30, Edoardo Baglivo31, Ekaterina Denisova32, Elisabetta Miserocchi33, Ester Carreno34, Fatma Asyari35, Francesco Pichi36, H Nida Sen37, Harvey Uy38, Heloisa Nascimento25, Ilknur Tugal-Tutkun39, J Fernando Arevalo40, Janet Davis41, Jennifer Thorne42, Joyce Hisae Yamamoto43, Justine Smith44, Justus G Garweg45, Jyotirmay Biswas46, Kalpana Babu47, Kanika Aggarwal4, Luca Cimino48, Lucia Kuffova49, Mamta Agarwal46, Manfred Zierhut50, Manisha Agarwal51, Marc De Smet52, Maria Sofia Tognon53, Marie-Helene Errera54, Marion Munk24, Mark Westcott2, Masoud Soheilian55, Massimo Accorinti56, Moncef Khairallah57, Myhanh Nguyen58, Onn Minn Kon59, Padmamalini Mahendradas60, Peizeng Yang61, Piergiorgio Neri36, Pinar Ozdal62, Radgonde Amer63, Richard Lee2, Rina La Distia Nora35, Romi Chhabra64, Rubens Belfort25, Salil Mehta65, Samir Shoughy66, Saurabh Luthra67, Shelina Oli Mohamed68, Soon-Phaik Chee69, Soumyava Basu70, Stephen Teoh71, Sudha Ganesh46, Talin Barisani-Asenbauer72, Yan Guex-Crosier73, Yılmaz Ozyazgan39, Yonca Akova74, Zohar Habot-Wilner75, John Kempen76, Quan Dong Nguyen7, Carlos Pavesio2, Vishali Gupta4.   

Abstract

Purpose: To standardize a nomenclature system for defining clinical phenotypes, and outcome measures for reporting clinical and research data in patients with ocular tuberculosis (OTB).
Methods: Uveitis experts initially administered and further deliberated the survey in an open meeting to determine and propose the preferred nomenclature for terms related to the OTB, terms describing the clinical phenotypes and treatment and reporting outcomes.
Results: The group of experts reached a consensus on terming uveitis attributable to tuberculosis (TB) as tubercular uveitis. The working group introduced a SUN-compatible nomenclature that also defines disease "remission" and "cure", both of which are relevant for reporting treatment outcomes.
Conclusion: A consensus nomenclature system has been adopted by a large group of international uveitis experts for OTB. The working group recommends the use of standardized nomenclature to prevent ambiguity in communication and to achieve the goal of spreading awareness of this blinding uveitis entity.

Entities:  

Keywords:  Antitubercular therapy; Ocular tuberculosis; remission; tubercular uveitis; tuberculous; uveitis

Year:  2019        PMID: 31821096     DOI: 10.1080/09273948.2019.1653933

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.728


  9 in total

1.  Absence of Evidence as The Evidence Of Absence: The Curious Case of Latent Infection Causing Ocular Tuberculosis.

Authors:  Soumyava Basu
Journal:  Front Ophthalmol (Lausanne)       Date:  2022-05-02

2.  The Association between QuantiFERON-TB Gold Test and Clinical Manifestations of Uveitis in the United States.

Authors:  Mehmet Yakin; Natasha Kesav; Shuk Kei Cheng; Sonny Caplash; Sapna Gangaputra; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2021-05-02       Impact factor: 5.488

3.  Visual outcome and prognostic factors in cataract surgery in ocular tuberculosis.

Authors:  Samrat Chatterjee; Deepshikha Agrawal; Swapnil M Parchand; Anupam Sahu
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

Review 4.  Ocular tuberculosis: Where are we today?

Authors:  Ilaria Testi; Rupesh Agrawal; Salil Mehta; Soumvaya Basu; Quan Nguyen; Carlos Pavesio; Vishali Gupta
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

Review 5.  Systemic immunosuppressive therapies for uveitis in developing countries.

Authors:  Hitesh Agrawal; Hien Doan; Brandon Pham; Amit Khosla; Manohar Babu; Peter McCluskey; Quan Dong Nguyen; Virender Sangwan; Subhakar Reddy; Sujata Sawhney; Mudit Tyagi
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

6.  Treatment Outcome of Tubercular Uveitis in a High TB and HIV Setting: A Prospective Cohort Study.

Authors:  Hassan Dawood Alli; Naseer Ally; Ismail Mayet; Lavania Joseph; Shaheed Omar; Shabir Madhi
Journal:  Clin Ophthalmol       Date:  2021-12-30

Review 7.  BTS clinical statement for the diagnosis and management of ocular tuberculosis.

Authors:  Onn Min Kon; Nicholas Beare; David Connell; Erika Damato; Thomas Gorsuch; Guy Hagan; Felicity Perrin; Harry Petrushkin; Jessica Potter; Charanjit Sethi; Miles Stanford
Journal:  BMJ Open Respir Res       Date:  2022-03

8.  Demography and clinical pattern of newly diagnosed uveitis patients in Malaysia.

Authors:  Rajasudha Sawri Rajan; Shelina Oli Mohamed; Mohamad Aziz Salowi
Journal:  J Ophthalmic Inflamm Infect       Date:  2022-09-01

9.  Role of secukinumab in ankylosing spondylitis with tubercular uveitis.

Authors:  Padmamalini Mahendradas; Vikramraj K Jain; Sherina Thomas; Ankush Kawali; Srinivasan Sanjay; Bhujang K Shetty
Journal:  Indian J Ophthalmol       Date:  2020-11       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.